Atlas Trials

Effects of Isotretinoin on CYP2D6 Activity

Clinical trial NCT03076021 · COMPLETED

Trial details

NCT number
NCT03076021
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
CYP2D6 Polymorphism
Start date
2016-07-26
Primary completion
2023-11-27
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.